Pure Global
NCT05293067

Troponin In Carotid Revascularization

University of Belgrade·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
high-sensitive troponin
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University of Belgrade
Location
Belgrade, Serbia
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2022
End date
Apr 01, 2024
Enrollment
240 participants
Primary outcome

The incidence of myocardial injury,The incidence of myocardial injury,The incidence of myocardial infarction,The incidence of myocardial infarction,The rate of cardiac-related death,The rate of cardiac-related death,The incidence of stroke,The incidence of stroke,The rate of all-cause mortality,The rate of all-cause mortality

Summary

Patients undergoing carotid revascularization procedures are at increased risk for the
 development of short- and long-term cardiac complications. Increased values of high-sensitive
 troponin may be useful in a timely selection of those patients. Still, contemporary
 literature doesn't provide enough data to answer the following questions: Can high-sensitive
 troponin predict adverse cardiac outcomes perioperatively in carotid surgery?, Should these
 cardiac biomarkers be routinely sampled in all patients undergoing carotid
 revascularization? and Can elevated levels of high-sensitive troponin preoperatively
 designate patients in whom the risk of surgical treatment (at a given moment) is greater than
 the benefit of the surgery?.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05293067
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05293067 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Belgrade and is currently Not yet recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.